Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
novartis
3
×
amgen
clinical trials
eli lilly
fda
indiana blog main
indiana top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
alder biopharmaceuticals
alirocumab
alnylam pharmaceuticals
avapritinib
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
cancer
cancer drugs
capmatinib
chronic migraine
david rind
deals
detroit blog main
detroit top stories
episodic migraine
eptinezumab
erenumab
europe blog main
europe top stories
evolocumab
What
drug
3
×
fda
medicines
3
×
approval
new
acquire
address
agreed
amgen
approves
billion
blueprint
brings
cancer
candidates
carries
cash
certain
cholesterol
class
company
compound
deal
designed
developed
genetic
gets
head
latest
medco
migraine
nod
novartis
pain
pass
poised
preventive
ready
ret
signature
Language
unset
Current search:
novartis
×
drug
×
medicines
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines